Oregon
Phase 1 cancer trials in Oregon
64 Phase 1 cancer studies are recruiting participants at sites in 5 cities across Oregon as of November 17, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Oregon city with a recruiting study
By research area: Lung Cancer (22), Breast Cancer (16), Lymphoma (16), Prostate Cancer (6), Pancreatic Cancer (4).
Portland (55), Eugene (8), Tigard (2), Medford (1), Springfield (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Oregon
Basic details from each study's public record (the 12 most recently updated of 64). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
- Phase 1
- Ages 18 and older
- Female participants
- Sponsor
- Totus Medicines
- Recruiting in
- Tigard
- Registry record
- NCT05683418 · updated
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Recruiting in
- Portland
- Registry record
- NCT06253871 · updated
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Recruiting in
- Portland
- Registry record
- NCT06638307 · updated
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Recruiting in
- Eugene · Portland
- Registry record
- NCT05579366 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Oregon on ClinicalTrials.gov.
Lung cancer: recently updated in Oregon
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Novelty Nobility, Inc.
- Recruiting in
- Portland
- Registry record
- NCT06805825 · updated
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Recruiting in
- Portland
- Registry record
- NCT07080242 · updated
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Portland
- Registry record
- NCT07227597 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Recruiting in
- Portland
- Registry record
- NCT07397338 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Oregon on ClinicalTrials.gov.
Prostate cancer: recently updated in Oregon
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Regeneron Pharmaceuticals
- Recruiting in
- Portland
- Registry record
- NCT03972657 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Oregon on ClinicalTrials.gov.
Lymphoma: recently updated in Oregon
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Recruiting in
- Portland
- Registry record
- NCT04726241 · updated
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Nurix Therapeutics, Inc.
- Recruiting in
- Eugene
- Registry record
- NCT07520006 · updated
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Phase 1/2
- Up to age 1
- All sexes
- Sponsor
- Tanja Andrea Gruber
- Recruiting in
- Portland
- Registry record
- NCT05848687 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Oregon on ClinicalTrials.gov.
Ask about studies in Oregon
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections